Findings

What do systematic reviews say?

1 questions · 1 findings · 1 reviews

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 1 · 100%

Clinical remission · people with Crohn's disease

Vedolizumab leads to higher induction of clinical remission (6–10 weeks) compared with placebo (high certainty).

1 finding from 1 review

Vedolizumab for induction and maintenance of remission in Crohn's disease 2023 · Cochrane Headline outcomes only
RR 1.61 [1.2, 2.17]
4 studies · 1126 participants
High